Bookmark and Share

Compound Summary for: CID 11450633

alogliptin

Also known as: UNII-JHC049LO86; CHEMBL376359; 850649-61-5; CHEBI:72323; MolPort-005-933-065
Molecular Formula: C18H21N5O2   Molecular Weight: 339.39164   InChIKey: ZSBOMTDTBDDKMP-OAHLLOKOSA-N
Alogliptin is a selective, orally-bioavailable inhibitor of enzymatic activity of dipeptidyl peptidase-4 (DPP-4). Chemically, alogliptin is prepared as a benzoate salt and exists predominantly as the R-enantiomer (>99%). It undergoes little or no chiral conversion in vivo to the (S)-enantiomer. FDA approved January 25, 2013.    From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Pharmacology
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _